Chemo‐enzymatic Synthesis of Pseudo‐trisaccharide Aminoglycoside Antibiotics with Enhanced Nonsense Read‐through Inducer Activity-Reference-Cited by-同舟云学术

Chemo‐enzymatic Synthesis of Pseudo‐trisaccharide Aminoglycoside Antibiotics with Enhanced Nonsense Read‐through Inducer Activity

Published:2022-11-08 Issue:1 Volume:18 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Lee Na Joon¹,Kang Woongshin²,Kwon Younghae²,Oh Jae Wook²,Jung Hogwuan²,Seo Minsuk²,Seol Yurin²,Wi Jae Bok¹,Ban Yeon Hee³,Yoon Yeo Joon³,Park Je Won¹⁴^ORCID

Affiliation:

1. Department of Integrated Biomedical and Life Sciences Korea University 02841 Seoul (Republic of Korea

2. Transdisciplinary Major in Learning Health Systems Department of Integrated Biomedical and Life Sciences Korea University 02841 Seoul (Republic of Korea

3. College of Pharmacy Natural Products Research Institute Seoul National University 08826 Seoul (Republic of Korea

4. School of Biosystems and Biomedical Sciences Korea University 02841 Seoul (Republic of Korea

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200497

Reference35 articles.

1. 2-Deoxystreptamine-containing aminoglycoside antibiotics: Recent advances in the characterization and manipulation of their biosynthetic pathways

2. Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs

3. Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis

4. Recognition of Cognate Transfer RNA by the 30 S Ribosomal Subunit

5. Molecular Insights into Aminoglycoside Action and Resistance

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of ST15-KL112 Klebsiella pneumoniae Co-Harboring Blaoxa-232 and rmtF in China;Infection and Drug Resistance;2024-07

2. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development;Biomolecules;2023-06-14